Where the Comment is King

THE NEWS COMMENTER

VOTE  (0)  (0)

J&J's one-dose coronavirus vaccine just won a critical thumbs-up from an FDA panel, paving the way for US authorization

Added 02-26-21 05:14:01pm EST - “US regulators will likely authorize the single-dose vaccine in the coming days, boosting the nation's immunization campaign.” - Businessinsider.com

CLICK TO SHARE

Posted By TheNewsCommenter: From Businessinsider.com: “J&J's one-dose coronavirus vaccine just won a critical thumbs-up from an FDA panel, paving the way for US authorization”. Below is an excerpt from the article.

Johnson & Johnson's experimental coronavirus vaccine just passed a critical hurdle, as a group of top doctors and scientists voted unanimously to endorse the shot.

The US Food and Drug Administration is now expected to authorize the vaccine to be given widely in the coming days. The FDA typically follows the panel's advice, but isn't required to do so. An emergency use authorization (EUA) would likely allow the shot to be given widely to people 18 and older. 

FDA regulators released their own summary of J&J's data on Wednesday, finding the shot to be safe and effective. 

The healthcare giant ran a study with about 40,000 volunteers, comparing its vaccine to a placebo. That trial found the shot was 66% effective at preventing moderate-to-severe COVID-19. The first two US-authorized vaccines demonstrated 94% and 95% efficacy at preventing symptomatic cases of COVID-19, though experts cautioned against comparing those figures directly.

A key challenge for J&J's shot will be explaining to the general public how it compares to the other vaccines, committee members said.

Read more...

If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.

CLICK TO SHARE

BACK TO THE HOME-PAGE